Trial intelligence / Profile preview

Terbutaline Turbuhaler vs Salbutamol pMDI in Japanese Asthma Patients

NCT01096017Phase 3Completed

Sponsor
AstraZeneca
Start
Mar 2010
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of terbutaline in asthma, sponsored by AstraZeneca. Started Mar 2010; status: completed.

02

Drugs

terbutaline
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01096017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01096017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call